
Transchem Ltd Upgraded to Sell as Technicals Improve Despite Weak Financials
2026-04-17 08:02:59Transchem Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 16 Apr 2026. This change is primarily driven by a marked improvement in technical indicators, even as the company continues to grapple with weak financial fundamentals and valuation concerns. The stock’s recent price surge and bullish technical signals contrast with ongoing operational losses and deteriorating profitability metrics, presenting a complex picture for investors.
Read full news article
Transchem Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Technicals
2026-04-16 08:08:15Transchem Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 15 Apr 2026. This adjustment reflects a complex interplay of deteriorating financial fundamentals, challenging valuation metrics, and mixed technical signals, despite some recent positive price momentum. Investors should carefully consider these factors amid the company’s ongoing operational struggles and market volatility.
Read full news article
Transchem Ltd Upgraded from Strong Sell to Sell Amid Mixed Financial and Technical Signals
2026-04-13 08:02:57Transchem Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 10 April 2026. This change is primarily driven by a marked improvement in technical indicators, even as the company continues to grapple with weak financial fundamentals and valuation concerns. The stock’s recent price surge and technical momentum have prompted a reassessment, though caution remains warranted given ongoing operational losses and negative returns on capital.
Read full news article
Transchem Ltd is Rated Strong Sell
2026-04-06 10:10:39Transchem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 02 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 06 April 2026, providing investors with the latest perspective on the company’s position.
Read full news article
Transchem Ltd is Rated Strong Sell
2026-03-26 10:10:36Transchem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 2 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Transchem Ltd is Rated Strong Sell
2026-03-15 10:10:32Transchem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 2 March 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 15 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Transchem Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Technical Signals
2026-03-03 08:07:39Transchem Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 2 March 2026, reflecting a complex interplay of deteriorating financial fundamentals, cautious valuation metrics, and mixed technical signals. Despite impressive long-term returns, recent quarterly losses and weakening operational metrics have raised concerns among analysts, prompting a reassessment of the stock’s outlook.
Read full news article
Transchem Ltd Upgraded from Strong Sell to Sell Amid Mixed Technical and Financial Signals
2026-02-24 08:04:10Transchem Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by improved technical indicators despite ongoing financial challenges. The pharmaceutical and biotechnology company’s recent performance reveals a complex picture where technical momentum contrasts with deteriorating fundamentals, prompting a nuanced reassessment of its investment appeal.
Read full news article
Transchem Ltd is Rated Strong Sell
2026-02-20 10:10:49Transchem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 20 February 2026, providing investors with the most up-to-date insight into the stock’s fundamentals and market performance.
Read full news articleFormat of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
15-Apr-2026 | Source : BSEFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Transchem Ltd- |
| 2 | CIN NO. | L66120MH1976PLC019327 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 0.00 |
| 4 | Highest Credit Rating during the previous FY | NA |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
Designation: Company Secretary and Compliance Officer
EmailId: secretary@transchem.net
Designation: Chief Financial Officer
EmailId: sarita@transchem.net
Date: 15/04/2026
Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Apr-2026 | Source : BSEPlease refer the attached intimation.
Closure of Trading Window
24-Mar-2026 | Source : BSEPlease refer the attached intimation.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






